| 000 -LEADER |
|---|
| fixed length control field |
05770cam a2200349 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
914593652 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200917104535.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
151211t20172017paua b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2015048962 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781451191004 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1451191006 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781496320575 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1496320573 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
YDX |
| -- |
BTCTA |
| -- |
YDXCP |
| -- |
NLM |
| -- |
OCLCF |
| -- |
IAX |
| -- |
NRC |
| -- |
SISPL |
| -- |
CUV |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
MMV |
| -- |
OHS |
| -- |
MMU |
| -- |
GTA |
| -- |
OCLCQ |
| -- |
DHA |
| -- |
TOL |
| -- |
UtOrBLW |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 10 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RM301 |
| Item number |
.P65 2017 |
| 130 0# - MAIN ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Principles of pharmacology (Golan) |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Principles of pharmacology : |
| Remainder of title |
the pathophysiologic basis of drug therapy / |
| Statement of responsibility, etc |
David E. Golan, editor in chief ; Ehrin J. Armstrong, April W. Armstrong, associate editors |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Fourth edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
2017 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xix, 1,020 pages : |
| Other physical details |
illustrations (some color) ; |
| Dimensions |
28 cm |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Miscellaneous information |
Section 1: Fundamental principles of pharmacology : -- |
| -- |
1. |
| Title |
Drug-receptor interactions / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
2. |
| Title |
Pharmacodynamics / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
3. |
| Title |
Pharmacokinetics / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
4. |
| Title |
Drug metabolism / |
| Statement of responsibility |
F. Peter Guengerich -- |
| Miscellaneous information |
5. |
| Title |
Drug transporters / |
| Statement of responsibility |
Keith A. Hoffmaster -- |
| Miscellaneous information |
6. |
| Title |
Drug toxicity / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
7. |
| Title |
Pharmacogenomics / |
| Statement of responsibility |
Kelan Tantisira -- |
| Miscellaneous information |
Section 2: Principles of neuropharmacology : -- |
| -- |
Section IIA: Fundamental principles of neuropharmacology : -- |
| -- |
8. |
| Title |
Principles of cellular excitability and electrochemical transmission / |
| Statement of responsibility |
Gary R. Strichartz -- |
| Miscellaneous information |
9. |
| Title |
Principles of nervous system physiology and pharmacology / |
| Statement of responsibility |
Daniel H. Lowenstein -- |
| Miscellaneous information |
Section IIB: Principles of autonomic and peripheral nervous system pharmacology : -- |
| -- |
10. |
| Title |
Cholinergic pharmacology / |
| Statement of responsibility |
Gary R. Strichartz -- |
| Miscellaneous information |
11. |
| Title |
Adrenergic pharmacology / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
12. |
| Title |
Local anesthetic pharmacology / |
| Statement of responsibility |
Gary R. Strichartz -- |
| Miscellaneous information |
Section IIC: Principles of central nervous system pharmacology : -- |
| -- |
13. |
| Title |
Pharmacology of GABAergic and glutamatergic neurotransmission / |
| Statement of responsibility |
Eng H. Lo -- |
| Miscellaneous information |
14. |
| Title |
Pharmacology of dopaminergic neurotransmission / |
| Statement of responsibility |
Victor W. Sung -- |
| Miscellaneous information |
15. |
| Title |
Pharmacology of serotonergic and central adrenergic neurotransmission / |
| Statement of responsibility |
Roy H. Perlis -- |
| Miscellaneous information |
16. |
| Title |
Pharmacology of abnormal electrical neurotransmission in the central nervous system / |
| Statement of responsibility |
Daniel H. Lowenstein -- |
| Miscellaneous information |
17. |
| Title |
General anesthetic pharmacology / |
| Statement of responsibility |
Keith W. Miller -- |
| Miscellaneous information |
18. |
| Title |
Pharmacology of analgesia / |
| Statement of responsibility |
Clifford J. Woolf -- |
| Miscellaneous information |
19. |
| Title |
Pharmacology of drugs of abuse / |
| Statement of responsibility |
Sachin Patel -- |
| Miscellaneous information |
Section III: Principles of cardiovascular pharmacology : -- |
| -- |
20. |
| Title |
Pharmacology of cholesterol and lipoprotein metabolism / |
| Statement of responsibility |
David E. Cohen -- |
| Miscellaneous information |
21. |
| Title |
Pharmacology of volume regulation / |
| Statement of responsibility |
Seth L. Alper -- |
| Miscellaneous information |
22. |
| Title |
Pharmacology of vascular tone / |
| Statement of responsibility |
Joseph Loscalzo -- |
| Miscellaneous information |
23. |
| Title |
Pharmacology of hemostasis and thrombosis / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
24. |
| Title |
Pharmacology of cardiac rhythm / |
| Statement of responsibility |
David E. Clapham -- |
| Miscellaneous information |
25. |
| Title |
Pharmacology of cardiac contractility / |
| Statement of responsibility |
Ehrin J. Armstrong -- |
| Miscellaneous information |
26. |
| Title |
Integrative cardiovascular pharmacology: hypertension, ischemic heart disease, and heart failure / |
| Statement of responsibility |
Ehrin J. Armstrong -- |
| Miscellaneous information |
Section IV: Principles of endocrine pharmacology : -- |
| -- |
27. |
| Title |
Pharmacology of the hypothalamus and pituitary gland / |
| Statement of responsibility |
Ursula B. Kaiser -- |
| Miscellaneous information |
28. |
| Title |
Pharmacology of the thyroid gland / |
| Statement of responsibility |
William W. Chin -- |
| Miscellaneous information |
29. |
| Title |
Pharmacology of the adrenal cortex / |
| Statement of responsibility |
Gail K. Adler -- |
| Miscellaneous information |
30. |
| Title |
Pharmacology of reproduction / |
| Statement of responsibility |
Robert L. Barbieri -- |
| Miscellaneous information |
31. |
| Title |
Pharmacology of the endocrine pancreas and glucose homeostasis / |
| Statement of responsibility |
Steven E. Shoelson -- |
| Miscellaneous information |
32. |
| Title |
Pharmacology of bone mineral homeostasis / |
| Statement of responsibility |
Ehrin J. Armstrong -- |
| Miscellaneous information |
Section V: Principles of chemotherapy : -- |
| -- |
33. |
| Title |
Principles of antimicrobial and antineoplastic pharmacology / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
34. |
| Title |
Pharmacology of bacterial infections: DNA replication, transcription, and translation / |
| Statement of responsibility |
Donald M. Coen -- |
| Miscellaneous information |
35. |
| Title |
Pharmacology of bacterial and mycobacterial infections: cell wall synthesis / |
| Statement of responsibility |
Sarah P. Hammond -- |
| Miscellaneous information |
36. |
| Title |
Pharmacology of fungal infections / |
| Statement of responsibility |
April W. Armstrong -- |
| Miscellaneous information |
37. |
| Title |
Pharmacology of parasitic infections / |
| Statement of responsibility |
Edward T. Ryan -- |
| Miscellaneous information |
38. |
| Title |
Pharmacology of viral infections / |
| Statement of responsibility |
Donald M. Coen -- |
| Miscellaneous information |
39. |
| Title |
Pharmacology of cancer: genome synthesis, stability, and maintenance / |
| Statement of responsibility |
David A. Frank -- |
| Miscellaneous information |
40. |
| Title |
Pharmacology of cancer: signal transduction / |
| Statement of responsibility |
David A. Frank -- |
| Miscellaneous information |
41. |
| Title |
Principles of combination chemotherapy / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
Section VI: Principles of inflammation and immune pharmacology : -- |
| -- |
42. |
| Title |
Principles of inflammation and the immune system / |
| Statement of responsibility |
April W. Armstrong -- |
| Miscellaneous information |
43. |
| Title |
Pharmacology of eicosanoids / |
| Statement of responsibility |
Charles N. Serhan -- |
| Miscellaneous information |
44. |
| Title |
Histamine pharmacology / |
| Statement of responsibility |
April W. Armstrong -- |
| Miscellaneous information |
45. |
| Title |
Pharmacology of hematopoiesis and immunomodulation / |
| Statement of responsibility |
George D. Demetri -- |
| Miscellaneous information |
46. |
| Title |
Pharmacology of immunosuppression / |
| Statement of responsibility |
April W. Armstrong -- |
| Miscellaneous information |
47. |
| Title |
Integrative inflammation pharmacology: peptic ulcer disease / |
| Statement of responsibility |
Helen M. Shields -- |
| Miscellaneous information |
48. |
| Title |
Integrative inflammation pharmacology: asthma / |
| Statement of responsibility |
Stephen Lazarus -- |
| Miscellaneous information |
49. |
| Title |
Integrative inflammation pharmacology: gout / |
| Statement of responsibility |
Lloyd B. Klickstein -- |
| Miscellaneous information |
Section VII: Environmental toxicology : -- |
| -- |
50. |
| Title |
Environmental toxicology / |
| Statement of responsibility |
Joshua M. Galanter -- |
| Miscellaneous information |
Section VIII: |
| Title |
Fundamentals of drug development and regulation -- |
| Miscellaneous information |
51. |
| Title |
Drug discovery and preclinical development / |
| Statement of responsibility |
Maarten Postema -- |
| Miscellaneous information |
52. |
| Title |
Clinical drug evaluation and regulatory approval / |
| Statement of responsibility |
Alexander E. Kuta -- |
| Miscellaneous information |
53. |
| Title |
Systematic detection of adverse drug events / |
| Statement of responsibility |
Jerry Avorn -- |
| Miscellaneous information |
Section IX: Frontiers in pharmacology : -- |
| -- |
54. |
| Title |
Protein therapeutics / |
| Statement of responsibility |
David E. Golan -- |
| Miscellaneous information |
55. |
| Title |
Drug delivery modalities / |
| Statement of responsibility |
Robert Langer |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacology |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Physiology, Pathological |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmacological Phenomena |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Therapy |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Golan, David E., |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Armstrong, Ehrin J., |
| Relator term |
editor |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Books |
